Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bjoern Papke

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Science (New York, N.Y.)|March 18, 2017
Drugging RAS: Know the enemyBjoern Papke, Channing J Der
United European Gastroenterology Journal|October 21, 2025
Unlocking RAS: Finding the Right Combination Is the KeyBjoern Papke, Channing J Der
Trends in Cancer|December 28, 2024
KRAS inhibitors: resistance drivers and combinatorial strategiesTamara Isermann, Christine Sers, Channing J Der, et al.
Biophysical Journal|January 14, 2014
The autodepalmitoylating activity of APT maintains the spatial organization of palmitoylated membrane proteinsNachiket Vartak, Bjoern Papke, Hernan E Grecco, et al.
ACS Pharmacology & Translational Science|April 16, 2021
Silencing of Oncogenic KRAS by Mutant-Selective Small Interfering RNABjoern Papke, Salma H Azam, Anne Y Feng, et al.
Cancer Research|November 8, 2022
Combination Therapies with CDK4/6 Inhibitors to Treat KRAS-Mutant Pancreatic CancerCraig M Goodwin, Andrew M Waters, Jennifer E Klomp, et al.
Cell Reports|June 20, 2020
Low-Dose Vertical Inhibition of the RAF-MEK-ERK Cascade Causes Apoptotic Death of KRAS Mutant CancersIrem Ozkan-Dagliyan, J Nathaniel Diehl, Samuel D George, et al.
Cancer Discovery|October 26, 2019
Atypical KRAS<sup>G12R</sup> Mutant Is Impaired in PI3K Signaling and Macropinocytosis in Pancreatic CancerG Aaron Hobbs, Nicole M Baker, Anne M Miermont, et al.
Cell Reports|June 17, 2026
Targeting p130Cas- and microtubule-dependent MYC regulation sensitizes pancreatic cancer to ERK MAPK inhibitionAndrew M Waters, Tala O Khatib, Bjoern Papke, et al.
Cell Reports|June 30, 2021
Targeting p130Cas- and microtubule-dependent MYC regulation sensitizes pancreatic cancer to ERK MAPK inhibitionAndrew M Waters, Tala O Khatib, Bjoern Papke, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Science (New York, N.Y.)|March 18, 2017
Drugging RAS: Know the enemyBjoern Papke, Channing J Der
United European Gastroenterology Journal|October 21, 2025
Unlocking RAS: Finding the Right Combination Is the KeyBjoern Papke, Channing J Der
Trends in Cancer|December 28, 2024
KRAS inhibitors: resistance drivers and combinatorial strategiesTamara Isermann, Christine Sers, Channing J Der, et al.
Biophysical Journal|January 14, 2014
The autodepalmitoylating activity of APT maintains the spatial organization of palmitoylated membrane proteinsNachiket Vartak, Bjoern Papke, Hernan E Grecco, et al.
ACS Pharmacology & Translational Science|April 16, 2021
Silencing of Oncogenic KRAS by Mutant-Selective Small Interfering RNABjoern Papke, Salma H Azam, Anne Y Feng, et al.
Cancer Research|November 8, 2022
Combination Therapies with CDK4/6 Inhibitors to Treat KRAS-Mutant Pancreatic CancerCraig M Goodwin, Andrew M Waters, Jennifer E Klomp, et al.
Cell Reports|June 20, 2020
Low-Dose Vertical Inhibition of the RAF-MEK-ERK Cascade Causes Apoptotic Death of KRAS Mutant CancersIrem Ozkan-Dagliyan, J Nathaniel Diehl, Samuel D George, et al.
Cancer Discovery|October 26, 2019
Atypical KRAS<sup>G12R</sup> Mutant Is Impaired in PI3K Signaling and Macropinocytosis in Pancreatic CancerG Aaron Hobbs, Nicole M Baker, Anne M Miermont, et al.
Cell Reports|June 17, 2026
Targeting p130Cas- and microtubule-dependent MYC regulation sensitizes pancreatic cancer to ERK MAPK inhibitionAndrew M Waters, Tala O Khatib, Bjoern Papke, et al.
Cell Reports|June 30, 2021
Targeting p130Cas- and microtubule-dependent MYC regulation sensitizes pancreatic cancer to ERK MAPK inhibitionAndrew M Waters, Tala O Khatib, Bjoern Papke, et al.
Pageof 1